Open AccessSerum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer
Author(s) -
Chang Liu,
Cathy Eng,
Jianjun Shen,
Yue Lu,
Yoko Takata,
Amir Mehdizadeh,
George J. Chang,
Miguel A. Rodrı́guez-Bigas,
Yanan Li,
Ping Chang,
Yiming Mao,
Manal M. Hassan,
Fangyu Wang,
Donghui Li
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.12841
Subject(s) - medicine , colorectal cancer , adjuvant therapy , biomarker , oncology , microrna , folfox , stage (stratigraphy) , cancer , primary tumor , adjuvant , gastroenterology , metastasis , oxaliplatin , biology , gene , paleontology , biochemistry
The study was aimed to evaluate the prognostic or predictive value of serum exosomal microRNAs (miRNAs) for tumor recurrence and response to adjuvant therapy in stage II and stage III colon cancer.